Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 May 15, 2015 Authorization to Discontinue Class Action Proceedings Against Theratechnologies Granted Apr 17, 2015 Supreme Court of Canada rules in favour of Theratechnologies Apr 14, 2015 Theratechnologies Announces Financial Results for First Quarter of 2015 Mar 30, 2015 Health Canada Approves 1mg/vial Presentation of EGRIFTA™ (tesamorelin for injection) Feb 27, 2015 Theratechnologies Annouces Commercialization Agreement for Egrifta (Tesamorelin for injection) in Europe Feb 26, 2015 Theratechnologies Announces Financial Results for Fiscal Year 2014 Feb 03, 2015 Theratechnologies announces voluntary filing of form 15 to suspend SEC reporting obligations Oct 08, 2014 Theratechnologies Announces Financial Results for Third Quarter of 2014 Sep 03, 2014 Theratechnologies resumes distribution of EGRIFTA® (Tesamorelin for injection) in the United States Jul 09, 2014 Theratechnologies Announces Financial Results for Second Quarter of 2014 First page « Previous page ‹ … Page 30 Page 31 Page 32 Page 33 Current page 34 Page 35 Page 36 Page 37 Page 38 Next page › Last page » Displaying 331 - 340 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Feb 27, 2015 Theratechnologies Annouces Commercialization Agreement for Egrifta (Tesamorelin for injection) in Europe
Feb 03, 2015 Theratechnologies announces voluntary filing of form 15 to suspend SEC reporting obligations
Sep 03, 2014 Theratechnologies resumes distribution of EGRIFTA® (Tesamorelin for injection) in the United States
